Answers are grounded in this paper and cite their sources.
We found an association between HLA-E*0103 homozygosity and the significant reduction of transplant-related mortality in related and unrelated HSCT. The risk of posttransplant complications was significantly reduced when the donor possesses the HLA-E*0103, 0103 genotype, and this was translated in a better overall survival.
No takes yet. Share an insight, caveat, or question.
Danzer et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: